1grh: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "1grh" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1grh.png|left|200px]] | [[Image:1grh.png|left|200px]] | ||
{{STRUCTURE_1grh| PDB=1grh | SCENE= }} | {{STRUCTURE_1grh| PDB=1grh | SCENE= }} | ||
===INHIBITION OF HUMAN GLUTATHIONE REDUCTASE BY THE NITROSOUREA DRUGS 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND 1-(2-CHLOROETHYL)-3-(2-HYDROXYETHYL)-1-NITROSOUREA=== | ===INHIBITION OF HUMAN GLUTATHIONE REDUCTASE BY THE NITROSOUREA DRUGS 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND 1-(2-CHLOROETHYL)-3-(2-HYDROXYETHYL)-1-NITROSOUREA=== | ||
{{ABSTRACT_PUBMED_3338461}} | {{ABSTRACT_PUBMED_3338461}} | ||
==About this Structure== | ==About this Structure== | ||
[[1grh]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GRH OCA]. | [[1grh]] is a 1 chain structure of [[Glutathione Reductase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GRH OCA]. | ||
==See Also== | |||
*[[Glutathione Reductase|Glutathione Reductase]] | |||
==Reference== | ==Reference== | ||
Revision as of 18:50, 26 July 2012
INHIBITION OF HUMAN GLUTATHIONE REDUCTASE BY THE NITROSOUREA DRUGS 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND 1-(2-CHLOROETHYL)-3-(2-HYDROXYETHYL)-1-NITROSOUREA
Template:ABSTRACT PUBMED 3338461
About this Structure
1grh is a 1 chain structure of Glutathione Reductase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Karplus PA, Krauth-Siegel RL, Schirmer RH, Schulz GE. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Eur J Biochem. 1988 Jan 15;171(1-2):193-8. PMID:3338461